Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabuyin Pills for girls with incomplete precocious puberty
ChiCTR2300074808Phase 4Recruiting
- Sponsor
- Children's Hospital of Fudan University
- Start
- Jul 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Dabuyin Wan in precocious puberty and premature thelarche (PT) (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: Composite efficacy score of breast nodule index, uterine volume, ovarian volume, and maximum follicle diameter. Started Jul 2023; status: recruiting.
02
Drugs
Dabuyin Wan
03
Conditions
precocious pubertypremature thelarche (PT)
Beyond the preview
Go deeper on ChiCTR2300074808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074808.